🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kieran Adam

University of Pittsburgh

ORCID: 0000-0003-0787-6868

Also affiliated with Columbia University Irving Medical Center, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors”.

Single-cell RNA sequencing reveals distinct T cell populations in immune-related adverse events of checkpoint inhibitors

Cell Reports Medicine(2022)10.1016/j.xcrm.2022.100868
N/A
0.665DataRank · unranked
83 citations

Brian S. Henick, Robert Winchester, Shalom Lerrer, Kieran Adam, Yevgeniya Gartshteyn +12 more

SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function

Inflammation(2021)10.1007/s10753-021-01437-8
N/A
0.470DataRank · unranked
22 citations

Kieran Adam, Shalom Lerrer, Johanna Straube, Sabina Sandigursky, Beatrix Ueberheide +2 more

Inhibition of IL-25/IL-17RA improves immune-related adverse events of checkpoint inhibitors and reveals antitumor activity

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008482
N/A
0.416DataRank · unranked
15 citations

Shoiab Bukhari, Carly Tymm, Kieran Adam, Shalom Lerrer, Brian S. Henick +3 more

PD-1-stimulated T cell subsets are transcriptionally and functionally distinct

iScience(2021)10.1016/j.isci.2021.103020
N/A
0DataRank · unranked
22 citations

Anna S. Tocheva, Shoiab Bukhari, Kieran Adam, Adam Mor, Shalom Lerrer

VRK2 inhibition synergizes with PD-1 blockade to improve T cell responses

Immunology Letters(2021)10.1016/j.imlet.2021.03.007
N/A
0DataRank · unranked
13 citations

Anna S. Tocheva, Kieran Adam, Adam Mor, Michael Peled

Data on the identification of VRK2 as a mediator of PD-1 function

Data in Brief(2021)10.1016/j.dib.2021.107168
N/A
0DataRank · unranked
3 citations

Kieran Adam, Adam Mor, Michael Peled

Transmembrane adaptor protein PAG is a mediator of PD-1 inhibitory signaling in human T cells

Communications Biology(2021)10.1038/s42003-021-02225-8
N/A
0DataRank · unranked
24 citations

Inbar Azoulay‐Alfaguter, Michael Peled, Kieran Adam, Adam Mor, Marianne Strazza

SLAMF6 compartmentalization enhances T cell functions

Life Science Alliance(2022)10.26508/lsa.202201533
N/A
0DataRank · unranked
21 citations

Anca Askanase, Ruijiang Song, Shoiab Bukhari, Matthew A. Dragovich, Kieran Adam +2 more

Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.10.012
N/A
0DataRank · unranked
6 citations

Emily K. Moore, Kieran Adam, Inbar Azoulay‐Alfaguter, Adam Mor, Marianne Strazza

Baseline peripheral T-cell composition in relation to radiographic phenotypes of immune-related pneumonitis.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2545
N/A
0DataRank · unranked
0 citations

Shoiab Bukhari, Robert Winchester, Ziyan Lin, Alireza Khodadad-Jamayran, Aristotelis Tsirigos +12 more

Advances in LAG3 cancer immunotherapeutics

Trends in cancer(2024)10.1016/j.trecan.2024.10.009
N/A
0DataRank · unranked
24 citations

Samuel C. Butler, Creg J. Workman, Dario A.A. Vignali, Kieran Adam

A novel mouse model for checkpoint inhibitor-induced adverse events

PLoS ONE(2021)10.1371/journal.pone.0246168
N/A
0DataRank · unranked
63 citations

Alina C. Iuga, Anna S. Tocheva, Adam Mor, Kieran Adam